Updated 08:05 GMT, 20 Nov 2026 SPX 7,175.83 -2.02% NDX 26,517.05 -2.21% VIX 28.44 +15.80% GOLD 3,574.90 -3.00% CL 82.63 -0.70% BTC 61,735.58 -0.27%
NAS100 26,517 −2.21% S&P 7,176 −2.02% GOLD $3,575 −3.00% BTC $61,736 −0.27% VIX 28.44 +15.80% latest tape · as of 08:05 UTC
The Screen · Consumer Cyclical

Abercrombie & Fitch Co. logoAbercrombie & Fitch Co.

ANF · the NYSE · USD · Market cap $6.3B

FAIL · Does not pass the screen
137.64 USD

Price as of 19 Nov 2026Daily close, not a live quote

Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price137.64 USD at the 19 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 19 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans to puts (put/call 2.03)
  • Last reviewed19 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $155.07 to $258.46, base estimate $185.00 (screen dated 2026-11-19).

Current read
Markup ?
Undervalued · screened 2026-11-19
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 2.03, read 2026-11-19
  • Ethical does not pass the values gate
Price137.64 USD
Fair value185.00
Value readUndervaluedas of 19 Nov 2026
Our investment reviews on this name
2026-11-09Read Markup149.54-8.0% to today Accumulation gives way to Markup first Markup read since August
2026-10-19Read Accumulation151.99-9.4% to today Markdown gives way to Accumulation after a 15% rise in 2 weeks
2026-10-02Read Markdown132.25+4.1% to today Markup gives way to Markdown after a 28% rise in 6 weeks
2026-08-21Read Markup103.38+33.1% to today ✓Markdown gives way to Markup after a 37% rise in 7 weeks

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Abercrombie & Fitch Co. holds its Markup at $137.64. Elevated stress, defensive posture warranted, held for 36 days.

As held on the ledger · 2026-11-19
PhaseMarkup
Quantitative stateElevated stress, defensive posture warranted, held for 36 days
Price at the screen$137.64
Valuation12.91 trailing · 11.59 forward price to earnings
Values screenFAIL
Beta0.98
The Workings

Five Screens: ANF's Results

FAIL. Debt ratio

TestFigureLimitStatus
Business activity Permissible Permissible core business Pass
Debt load 34.03% Below 33% Fail
Interest-bearing cash 22.86% Below 33% Pass
Receivables 0.00% Below 49% Pass
Revenue purity 0.46% Below 5% Pass

Definitions, sources and threshold rules: ticker values-screen methodology.

The Ethical Read

Why It Falls Short, in Plain English

Abercrombie & Fitch's business is in a permissible area, but its interest-bearing debt is about 34% of the company, just over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when ANF's ethical verdict changes

Today ANF does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 19 Nov 2026: it trades at roughly a 26% discount to our $185.00 fair value, moderate competitive moat, 4.80% revenue growth.

Model construction and limits: fair-value methodology.

155.07Conservative185.00Base case258.46Growth case 137.64Price

Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 25.6% discount to the base estimate.

The Street's Range
134.00Street low 165.00Street average 185.00Street high 137.64Price

Third-party analyst targets: 11 covering, consensus Buy. The average target sits +20% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $185.00, with a range of $155.07 to $258.46, dated to the 2026-11-19 screen.

How our estimate and third-party targets differ.

The Business, in Plain Words

Fashion Chain's Cheap Multiple Hides Real Traps

Walk into any mall and you see how quickly trends shift from one season to the next. Abercrombie & Fitch shows solid returns on equity at 39 percent and a forward multiple of just 8.1 times, yet the business sits in a classic cyclical spot with revenue growing only 2 percent and a moderate moat that offers little protection when spending slows. The ethical screen flags the debt ratio straight away, so we pass.

The low multiple looks attractive next to a 9 percent profit margin and analyst targets around 110 dollars, but that is exactly the warning sign for cyclical names. Peak earnings often sit behind these compressed valuations, and any slowdown in consumer spending turns the apparent bargain into a trap rather than a margin of safety.

High debt adds another layer of fragility that the numbers alone do not fix. Currency moves, fashion missteps and rising interest costs can all hit at once. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E11.6xexpensive even after accounting for its growth
Trailing P/E12.9xreasonably valued
EPS, trailing11.58
EPS, forward12.91
Revenue growth+4.8%slow but positive growth
Profit margin10.0%thin but positive margins
Return on equity40.6%an exceptional return on shareholder capital
FCF yield6.87%
Debt to equity0.94moderate, manageable leverage
Current ratio1.41adequate liquidity, worth monitoring
Beta0.98steadier than the market
Short interest, float0.15%
52-week range65.45 - 172.00
MoatMODERATE
Market cap$6.3B

Metric definitions and interpretation rules: ticker-page methodology.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-19 Markup $147.01 +2.9% Entry 20

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 27% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it buy, with a mean price target of $171. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-18 Markup $142.88 -4.0% Entry 19

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 35% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it buy, with a mean price target of $171. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-17 Markup $148.88 +0.0% Entry 18

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 35% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it buy, with a mean price target of $171. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-16 Markup $148.88 -0.4% Entry 17

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 35% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it buy, with a mean price target of $168.

2026-11-09 Markup · changed $149.54 -9.1% Entry 16

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 9.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 35% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it buy, with a mean price target of $166.

2026-11-02 Accumulation $164.44 +8.2% Entry 15

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 46% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it buy, with a mean price target of $166.

2026-10-26 Accumulation $151.99 +0.0% Entry 14

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 46% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it buy, with a mean price target of $166.

2026-10-19 Accumulation · changed $151.99 +6.6% Entry 13

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 46% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it buy, with a mean price target of $164.

2026-10-12 Markdown $142.58 +7.8% Entry 12

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 7.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it buy, with a mean price target of $164.

2026-10-02 Markdown · changed $132.25 +27.9% Entry 11

The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 27.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (11 analysts) rates it none, with a mean price target of $164.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on ANF

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in ANF's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · ANF
DateInsiderTitleTypeSharesValue
2026-03-26 HOROWITZ FRAN Chief Executive Officer 290,904 ·
2026-03-26 LIPESKY SCOTT D Chief Operating Officer 70,522 ·
2026-03-26 HENCHEL GREGORY J General Counsel 24,684 ·
2026-03-26 DESAI SAMIR Chief Technology Officer 70,522 ·
2026-03-26 RUST JAY Officer 17,632 ·
2026-03-23 RUST JAY Officer 1,949 ·
2026-03-23 BALL ROBERT J Chief Financial Officer 780 ·
2026-03-23 FRERICKS JOSEPH Officer 780 ·
2026-03-12 RUST JAY Officer 1,037 ·
2026-03-12 BALL ROBERT J Chief Financial Officer 519 ·

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $162.01 -9.3% · $907 -9.3%
2 months $135.76 +8.3% · $1,083 +8.3%
3 months $105.02 +40.0% · $1,400 +40.0%
6 months $77.26 +90.3% · $1,903 +90.3%
1 year $69.52 +111.5% · $2,115 +111.5%
2 years $143.42 +2.5% · $1,025 +2.5%
3 years $73.57 +99.8% · $1,998 +99.8%
5 years $45.19 +225.3% · $3,253 +225.3%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever ANF does next, these words stay.

Abercrombie & Fitch Co. · ANF · Markup · $137.64
Recorded 2026-11-19 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.